Erythritol→Xylitol, cardiovascular research lineage of the same study
We have chronologically organized the results of repeated verification of sugar alcohol sweeteners by research teams affiliated with Cleveland Clinic and Charité University Hospital.
2023 · Erythritol correlation
Analysis of approximately 4,000 high-risk cardiovascular patients, risk of cardiovascular events within 3 years in the high blood erythritol concentration group is approximately 2 times higher (Nature Medicine)
August 2024 · Erythritol intervention study
Healthy volunteers, platelet reactivity significantly increased after consuming erythritol beverages (no change in sugar group)
2024 · Xylitol correlation (EHJ)
1,157 patients with a history of cardiovascular disease + 2,149 validation cohort, risk of cardiovascular events significantly increased in the high concentration group
August 2026 · ESC Xylitol general population cohort
17,710 general population (CLSA+EPIC-Norfolk), risk in high concentration group CLSA +57%(6 years) / EPIC-Norfolk +18%(30 years)
Includes results at the conference presentation stage that have not yet been published in a peer-reviewed journal.